Therapeutic upregulation of Cpt1a inhibits neonatal hyperoxia‐induced pulmonary vascular remodeling and right ventricular hypertrophy as well as pulmonary hypertension. This evidence concerns the gene CPT1A and Right ventricular hypertrophy.